Select the webinar and click on the Registration Link
At Innovative Care, we want to keep you informed about an important change regarding compounded semaglutide following the FDAs recent announcement
Customers tell us they want peace of mind so that if a consumer has their beverage across multiple day parts, they will have a large margin before hitting tolerance levels. Why beverage brands need to brace themselves The thirst for GLP-1 medication only looks set to increase among consumers with the launch of unfussy, non-injectable formats A pill version of the appetite-suppressing drug, Wegovy, was unveiled by pharma giant Novo Nordisk in January Eli Lilly & Co is preparing to debut its own oral version, Orforglipron, post-FDA approval later this year The total GLP-1 pill market is forecast to leap from $3.2bn in 2025 to 34.3 bn in 2031, a CAGR of 48.4% (GlobalData) (Source GlobalData) GLP-1 drink NPD outside the box Although, its not just traditional food and beverage companies developing tailored NPD
Its essential to discuss this with our healthcare team at Blue Sky Laser + Tox Medspa to ensure a comprehensive approach to your weight loss journey
You can take only about four sips of water with the daily pill, she explained, and then you have to wait 30 minutes before eating anything
